Shares of Sun Pharmaceutical Industries declined 2.10% to Rs 1,659 amid concerns over latest US tariff announcement. Last ...

Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7 players ...

India’s ₹10,000 crore Biopharma SHAKTI scheme marks a definitive shift from low-cost generics to high-value biologics, aiming ...

Kotak Securities Equity Research Head suggests placing bets on Vishal Mega Mart and Jubilant Ingrevia. Here's why ...

Dr. Reddy's, Sun Pharma, Zydus & others launch branded generics after patent expiry, targeting a ₹12,000-crore market ...

UroGen Pharma’s latest analyst update keeps the fair value target effectively anchored at US$35.63, with no reset in the central valuation estimate. Bullish voices see this as support for a ...

The iShares Future Exponential Technologies ETF is highly sensitive to cost of capital shifts, driven by its tech and ...

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives outlined growth drivers, competitive pressures, and pipeline priorities during a fireside chat at Needham & Company’s 25th Annual Healthcare ...

In this article, we will look at the stocks Jim Cramer discussed alongside the tech market divide. The host of CNBC’s Mad ...

Corvus (CRVS) stock's soquelitinib shows early promise in PTCL & atopic dermatitis, but a $1.24B valuation may be ahead of ...

Adding to concerns, IndiGo on Wednesday said it will increase fuel charges across domestic and international routes for bookings made from April 2, citing a steep rise in aviation turbine fuel prices ...

MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") today launches an offering of US$550 million convertible ...